Clinical Trial Update: U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating U-500R insulin delivered via Omnipod in adults with type 2 diabetes and severe insulin resistance; results completed and posted in 2013…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Humulin R U-500 (insulin regular (human))

Snippet

Sponsor: Mountain Diabetes and Endocrine Center | Conditions: Type 2 Diabetes, Insulin Resistance | Phase 4 | Status: COMPLETED | Results posted: 2013-12-30